Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(E)-[6]-Dehydroparadol ((6)-Dehydroparadol), an oxidative metabolite of [6]-Shogaol, is a potent Nrf2 activator.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 37.00 | |
2 mg | In stock | $ 53.00 | |
5 mg | In stock | $ 87.00 | |
10 mg | In stock | $ 147.00 | |
25 mg | In stock | $ 243.00 | |
50 mg | In stock | $ 377.00 | |
100 mg | In stock | $ 477.00 | |
500 mg | In stock | $ 977.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 96.00 |
Description | (E)-[6]-Dehydroparadol ((6)-Dehydroparadol), an oxidative metabolite of [6]-Shogaol, is a potent Nrf2 activator. |
Targets&IC50 | HCT116 cells:41.59 μM , HCT116 cells:43.02 μM |
In vitro | (E)-[6]-Dehydroparadol (5-80 µM; 24 h) inhibits the growth of HCT-116 and H-1299 cells, with IC50s of 43.02 and 41.59 µM, respectively. (E)-[6]-Dehydroparadol (10-40 µM; 24 h) induces apoptosis in HCT-116 and H-1299 cells[1]. |
In vivo | (E)-[6]-Dehydroparadol at a concentration of 5 µM for 24 hours increases the fluorescence signal of Tg[glutathione S-transferase pi 1 (gstp1):green fluorescent protein (GFP)] in Tg(gstp1:GFP) transgenic zebrafish embryos. |
Synonyms | (6)-Dehydroparadol |
Molecular Weight | 276.37 |
Formula | C17H24O3 |
CAS No. | 878006-06-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 120 mg/mL (434.2 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(E)-[6]-Dehydroparadol 878006-06-5 Immunology/Inflammation Nrf2 [6]-Dehydroparadol (6)-Dehydroparadol inhibitor inhibit